News > Longevity 2020From science fiction to FDA submission: ectopic organoids & the commercialization of regenerative medicine

From science fiction to FDA submission: ectopic organoids & the commercialization of regenerative medicine

Author:  |  Published on: April 30, 2020  |  Last updated: May 10, 2022

Michael Hufford

Co-Founder and CEO, LyGenesis

From science fiction to FDA submission: ectopic organoids & the commercialization of regenerative medicine


 

Editor's choice

Empowering cells to boost energy and recovery is a winning move

Study disproves benefits of probiotics for vaginal health

How do Tour De France athletes recover so fast? Performance coach reveals the secret

9 proven ways to beat brain fog and enhance your energy

Longevity investment platform opens-up to international investors

Urolithin A research opens door to osteoarthritis relief

Popular articles

Stay cool: the longevity tech that “shows insane promise”

Does SIRT6 hold the key to human longevity?

Tally up! Consumer longevity company lands $10m

Longevity: ‘money-spinning cult’ or the future of health?

Zuzalu: a pop-up city with longevity at its heart

Longevity AI partners with Israel’s leading HMO

More like this

It’s a brave new world – but longevity needs to stay in the realm of the credible

Economy

Unlocking longevity potential: GlycanAge’s approach to longevity, healthspan and menopause

Diagnostics

A strong patent portfolio delivers a competitive edge in the longevity space

Investment

Juvenescence: Think aging up, rather than disease down

Features

Combilytics: Taking a combined approach to senescence

Supplements

Investing in Longevity 101

Economy

Getting comfortable with senotherapeutics

Biotech

New longevity conference will span research to evidence-based clinical practice

Videos

Stay cool: the longevity tech that “shows insane promise”

Features

‘This conference is going to be the best yet’

Economy

GlycanAge: A novel platform for guiding improvements to longevity and healthspan

Diagnostics

From the cradle to the grave – the long way round

Videos

Mitochondrial therapy could tackle aging from the inside out

Biotech

Fountain Life: longevity real estate built on prevention and detection

Investment

Why finding out your GlycanAge could put more time on the clock

Diagnostics

More power to you – why energy could be the key to longevity

Biotech